Science and Technology  Committee - Minutes of Evidence
Pfizer's decision to close its research and development facility at Sandwich

Here you can browse the Minutes of Evidence which were ordered by the House of Commons to be printed 28 February 2011.

Oral Evidence

Taken before the Science and Technology Committee

on Monday 28 February 2011

Members present:

Andrew Miller (Chair)
Gavin BarwellPamela Nash
Stephen McPartlandGraham Stringer
Stephen MosleyRoger Williams



Examination of Witnesses

Witnesses: Dr Richard Barker, Director General, Association of the British Pharmaceutical Industry, and Dr David M Hollinshead, Royal Society of Chemistry, Science Policy Director, AstraZeneca, gave evidence.

Question Numbers


Examination of Witnesses

Witnesses: Dr Olivier Brandicourt, President and General Manager of Pfizer's Primary Care Business Unit, and co-chair of the company's Portfolio Strategy and Investment Committee, Dr Rod MacKenzie, Senior Vice President and Head of Worldwide Research for PharmaTherapeutics Research and Development, Dr Ruth McKernan, Senior Vice President and Site Head, Sandwich, and Chief Scientific Officer for Pfizer Regenerative Medicine, and Richard Blackburn, Managing Director, Pfizer UK, gave evidence.

Question Numbers


contents next page

© Parliamentary copyright 2011
Prepared 19 May 2011